高频胸壁振荡疗法在婴儿中的可行性随机对照试验方案
本研究为可行性随机对照临床试验方案,拟纳入30名3–6月龄健康婴儿,分三组评估Expector设备(袋鼠式背带版)不同振动配置的可行性与可用性。将在设备使用前、15分钟使用期间每5分钟及使用后15分钟评估心率、呼吸频率、血氧饱和度等指标,为后续随机对照研究提供初步证据。
要点
- 拟纳入30名3–6月龄健康婴儿,分三组评估Expector设备可行性。
- 设备使用15分钟,使用前、中每5分钟及使用后15分钟评估生理指标。
- 评估指标包括心率、呼吸频率、血氧饱和度、肺部听诊、睡眠觉醒状态、疼痛及家长满意度。
核心结论
- 本研究旨在评估Expector设备(袋鼠式背带版)在健康婴儿中的可行性与可用性,为后续随机对照研究提供初步证据。
研究设计与样本
- 可行性随机对照临床试验,拟纳入30名3–6月龄健康婴儿,分为三组。
- 两个实验组使用Expector设备(袋鼠式背带版),分别采用全部微型振动马达激活和上半部分马达激活两种配置。
- 对照组设备不激活。
关键数值与推荐
- 在测试前、15分钟设备使用期间每5分钟及使用后15分钟评估心率、呼吸频率、外周血氧饱和度、肺部听诊、睡眠/觉醒状态、疼痛及家长满意度。
- 数据将采用集中趋势和离散程度度量以及绝对和相对频率描述,统计分析包括相关分析及组内和组间比较。
临床怎么用
- 该研究将为Expector设备在婴儿中的可行性提供初步证据,并支持后续开展随机对照研究。
局限性
- 本研究为可行性试验方案,样本量30名健康婴儿,结果可能不足以支持临床有效性结论。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Introduction Since the inflammatory response increases the production and accumulation of mucus in the airways during respiratory infections, conventional and unconventional techniques of secretion removal are used. High-frequency chest wall oscillation is an effective strategy for secretion removal; however, it presents barriers due to the high cost. In Brazil, the Expector was developed using a kangaroo-vest interface as an accessible alternative; however, studies are needed to evaluate the use of Expector in infants. The aim of this study was to assess the feasibility and usability of the Expector device in healthy infants. Methods and analysis For this feasibility randomised controlled clinical trial, 30 participants aged 3–6 months will be divided into three groups. Two experimental groups will use the Expector device (kangaroo baby-carrier version) with different configurations of the minivibrating motors (ie, totally activated and upper half of motors activated). The device will be deactivated for the control group. The following parameters will be assessed before the test, every 5 min during 15 min of device use and for 15 min after its use: heart rate, respiratory rate, peripheral oxygen saturation, pulmonary auscultation, sleep/wakefulness state, pain and parental satisfaction. Data will be described using measures of central tendency and dispersion and absolute and relative frequencies. Statistical analysis will be performed using correlation and intra- and intergroup comparisons. This study will generate preliminary evidence regarding the feasibility of Expector (kangaroo baby-carrier version) for infants and allow randomised and controlled studies using this technology. Ethics and dissemination The Ethics Committee of the Faculty of Health Sciences of Trairi of the Federal University of Rio Grande do Norte approved this study (Number 5636504). Findings will be disseminated through peer-reviewed journal publications, scientific conference presentations and knowledge translation to the public via social media. Trial registration number This feasibility randomised controlled clinical trial was registered in the Brazilian Registry of Clinical Trials (REBEC) (Number RBR-5r8v8qz).
引用
- BMJ Open Respiratory Research:Use of high-frequency chest wall oscillation therapy in infants: protocol for a feasibility randomised controlled clinical trial
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。